Exploratory Study of Toumai Endoscopic Surgery System for Remote Gastrectomy
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Hebei
-
Shijiazhuang, Hebei, China, 050011
- Recruiting
- Department of General Surgery
-
Principal Investigator:
- Qun Zhao, Dortor
-
Contact:
- Qun Zhao, Doctor
- Phone Number: +8613930162111
- Email: zhaoqun516@yahoo.com.cn
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18 years old ≤ actual age ≤80 years old.
- Patients requiring gastrointestinal endoscopic surgery.
- Willing to cooperate with and complete the study follow-up and related examinations.
- Voluntarily participate in the study and sign the informed consent in person.
Exclusion Criteria:
- Have serious cardiovascular or circulatory disease and cannot tolerate surgery.
- Participated in other clinical trials within the last 3 months.
- Inability to understand trial requirements, or inability to complete the study follow-up plan.
- Researchers believe that there are other circumstances that are not suitable for inclusion.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: 5G remote gastrectomy
|
5G remote gastrectomy on subjects using the Toumai endoscopic surgery system
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The rate of intraoperative complications
Time Frame: The day of surgery
|
Intraoperative complications, including organ injury and vascular injury, were evaluated using the Satava grading system to determine whether the occurrence of complications was related to the study instrument or surgery
|
The day of surgery
|
|
The rate of postoperative complications
Time Frame: Postoperative 30 days
|
Postoperative complications, including postoperative bleeding, fever, and incisional infection, were evaluated using the Clavien-Dindo grading system to determine whether the occurrence of complications was related to the study instrument or surgery.
|
Postoperative 30 days
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Intraoperative system failure rate
Time Frame: The day of surgery
|
The day of surgery
|
|
Surgical completion rate
Time Frame: The day of surgery
|
The day of surgery
|
|
Intraoperative blood loss
Time Frame: The day of surgery
|
The day of surgery
|
|
Operation time
Time Frame: The day of surgery
|
The day of surgery
|
|
Preoperative device assembly time
Time Frame: The day of surgery
|
The day of surgery
|
|
Intraoperative instrument operation error rate
Time Frame: The day of surgery
|
The day of surgery
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimated)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- FUTURE-04
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.